Dentists leafing through The Journal of the American Dental Association last May found a study concluding that a new drug called Bextra offered relief from one of their patients' worst nightmares -- the acute pain that follows dental surgery. Federal regulators had rejected that conclusion only six months before, leaving Bextra's marketers, Pharmacia and Pfizer, hard pressed to sell it as an advance over Celebrex, their earlier entry in a crowded market for pain drugs. The new study helped light a fire under Bextra. Madison Ave. Has Growing Role In the Business of Drug Research Madison Ave. Has Growing Role In the Business of Drug Research
Dentists leafing through The Journal of the American Dental Association last May found a study concluding that a new drug called Bextra offered relief from one of their patients' worst nightmares - the acute pain that follows dental surgery. Federal regulators had rejected that conclusion only six months before, leaving Bextra's marketers, Pharmacia and Pfizer, hard pressed to sell it as an advance over Celebrex, their earlier entry in a crowded market for pain drugs. The new study helped light a fire under Bextra. Its sales soared 60 percent over the three months that followed, according to industry data. Big Pharma and Madison Avenue Big Pharma and Madison Avenue
Omnicom Group Inc. Omnicom Group Inc. (NYSE: OMC) is a leading global advertising and marketing communications services company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations and other specialty communications services to more than 5,000 clients in more than 100 countries. As a strategic holding company, Omnicom manages a portfolio of global market leaders comprised of three global advertising agency networks, BBDO, DDB and TBWA; numerous leading national advertising agencies; a global network of more than 175 marketing services companies; and a media group, Omnicom Media Group, that includes two of the world's premier providers of media planning and buying services. Omnicom Group - Home Omnicom Group - Home
Omnicom Group Inc. is an American global advertising, marketing and corporate communications holding company, headquartered in New York City. It is the world's top corporate media services conglomerate[1] and one of the "Big Four" agency companies (alongside WPP, Interpublic and Publicis).[2] The company oversees an international network of more than 1,500 agencies and provides services for over 5,000 clients in more than 100 countries.[3][4] Omnicom's agencies provide marketing and communications services in the disciplines of advertising, customer relationship management (CRM), strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations (PR) and other specialty communications. Omnicom’s agency networks include BBDO, DDB Worldwide, TBWA Worldwide, Diversified Agency Services (DAS) and Omnicom Media Group (OMG). Omnicom Group Omnicom Group
Interpublic Group: home
Interpublic Group of Companies Interpublic Group of Companies The Interpublic Group of Companies, Inc. (IPG) is one of the big four global advertising holding companies (the others being Omnicom, WPP and Publicis). It is headquartered in New York City and is the parent company of advertising and marketing services agencies around the world. The company consists of three major networks: McCann Worldgroup, Lowe and Partners, and Draftfcb. Its media agencies are bundled under the IPG Mediabrands entity. It also owns a number of specialty agencies, including public relations, sports marketing, talent representation and healthcare.[1]
WPP plc is a British multinational advertising and public relations company with its main management office in London, United Kingdom, and its executive office in Dublin, Ireland.[3] It is the world's largest advertising company by revenues, and employs around 162,000 people in 3,000 offices across 110 countries.[2][4] It owns a number of advertising, public relations and market research networks, including Grey, Burson-Marsteller, Hill & Knowlton, JWT, Ogilvy Group, TNS, Young & Rubicam and Cohn & Wolfe.[2] WPP has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on NASDAQ. History[edit] WPP plc WPP plc
Publicis Publicis On 28 July 2013, it was announced that Publicis Groupe and Omnicom Group would merge to form Publicis Omnicom Group.[3] Overview[edit] The company was founded by Marcel Bleustein-Blanchet in 1926.[4] The company owned several full-service advertising groups that undertake a range of media activities: mobile and interactive online communication, television, magazines & newspapers, cinema and radio, outdoor. The company's SAMS services include direct marketing/customer relationship management services, sales promotion, healthcare communications, multicultural and ethnic communications, corporate and financial communications, human resource infrastructure, public relations, design services, interactive communications, events marketing and management, sports marketing, and production and pre-press services.[5] Its media services include media planning, media buying, and media sales. Publicis Groupe's Vivaki pole has developed a technological platform supported by Microsoft, Google, Yahoo!
Torre Lazur
Scirex - Premier Research Scirex - Premier Research For more than 30 years, Premier Research has been conducting clinical research studies to evaluate investigational medication in a variety of medical conditions including acute and chronic pain. We have treated more than 90,000 study volunteers in over 350 clinical research studies. More recently, we have expanded our expertise to include the conduct of clinical studies on healthy volunteers. Our surgeons and physicians are experts in their fields, are board-certified, and have their own private practices.
The Social Study of Corporate Science: A Research Manifesto Bart Penders Annemiek Nelis Laboratory ethnographies have provided valuable insights in the workings of contemporary science and technology and about facts in the making. The Social Study of Corporate Science: A Research Manifesto
John Verbakel, Vice President Research and Development | Unilever
Prof Accuses Colleagues of Slanted Research By Paul Basken A University of Pennsylvania psychiatry professor has accused his department chairman and four colleagues of publishing an article that was ghostwritten on behalf of a pharmaceutical company and made unsupported claims for one of its best-selling drugs. The medical-journal article, published in 2001, "was biased in its conclusions" and "made unsubstantiated efficacy claims and downplayed" negative side effects of the antidepressant drug Paxil, according to a complaint filed by lawyers for Jay D. Amsterdam, a professor of psychiatry at Penn. Dr. Prof Accuses Colleagues of Slanted Research
Amsterdam, J.D., Newberg, A: Dopamine Transporter Density in Bipolar Type II and Unipolar Major Depressive Episode. Neuropsychobiology 55: 167-170, 2007. Michelson D, Adler L, Amsterdam JD, Dunner D, Nierenberg A, Reimherr F, Schatzberg Am Kelsey D, Williams D: Addition of atomoxetine for depression incompletely responsive to sertraline: A randomized, double blind, placebo controlled study. Journal of Clinical Psychiatry 68: 582-587, 2007. Newberg AB, Amsterdam JD, Shults J: Dopamine transporter density may be associated with the depressed affect in healthy subjects. Nuclear Medicine Communications 28(1): 3-6, 2007. Jay. D. Amsterdam
By Paul Basken Universities have been struggling for years with the problem of researchers who let industry-financed ghostwriters draft biased summaries of their work for publication in medical journals. They're now getting some blunt advice on how to stop it, including from perhaps the most qualified experts: the ghostwriters themselves. In a pair of articles published Tuesday by PLoS Medicine, two professional medical writers outlined changes that both universities and the journals could make. Universities Get Advice on How to Avoid Ghostwriting Scandals in Research Articles - Government
Citation: Logdberg L (2011) Being the Ghost in the Machine: A Medical Ghostwriter's Personal View. PLoS Med 8(8): e1001071. doi:10.1371/journal.pmed.1001071 Published: August 9, 2011 Copyright: © 2011 Linda Logdberg. Being the Ghost in the Machine: A Medical Ghostwriter's Personal View
Image oAqR
Helen Hayes Hospital | The Power of Rehabilitation
Linda Logdberg - Georgia Perimeter College [all campuses]
? Linda Logdberg ?
Dr Logdberg's webpage
Authorship rules for medical journals flouted by pharma industry, experts say
How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised
Image L2Jx
ICMJE: Uniform Requirements for Manuscripts Submitted to Biomedical Journals
Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles
Carrie Wolinetz
Carrie Wolinetz (Dr_CarrieDale) sur Twitter
Medicijn op zoek naar een ziekte
Trouw: Wetenschappelijke fraude komt vaker voor
Harvard Medical School Professor Among Five Accused of Ghostwriting
Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey
NTvG: Onrechtmatig auteurschap nog steeds grootschalig probleem